Piperacillin and Tazobactam and Sodium Chloride

{
  "unii": {
    "unii": "M98T69Q7HP",
    "rxcui": "203134",
    "inchikey": "WCMIIGXFCMNQDS-IDYPWDAWSA-M",
    "display_name": "PIPERACILLIN SODIUM",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "a63ca653-27d4-45fe-a744-77e0efe45220": {
      "match": "brand_token",
      "title": "PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE INJECTION, SOLUTION [B. BRAUN MEDICAL INC.]",
      "spl_version": "12",
      "published_date": "2026-05-13"
    }
  },
  "productid": "0264-3450_7c603d0f-caa7-4da2-a44b-dd19fa04b631",
  "productndc": "0264-3450",
  "dosage_form": "INJECTION, SOLUTION",
  "orange_book": {
    "appl_no": "206056",
    "products": [
      {
        "rs": true,
        "rld": true,
        "te_code": null,
        "strength": "EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL",
        "product_no": "001",
        "approval_date": "Apr 3, 2025"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": null,
        "strength": "EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL",
        "product_no": "002",
        "approval_date": "Apr 3, 2025"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": null,
        "strength": "EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL",
        "product_no": "003",
        "approval_date": "Apr 3, 2025"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "shortage_reason": "Piperacillin and Tazobactam Injection",
  "shortage_status": "current",
  "proprietary_name": "Piperacillin and Tazobactam and Sodium Chloride",
  "active_ingred_unit": "g/100mL; mg/100mL",
  "application_number": "NDA206056",
  "marketing_category": "NDA",
  "nonproprietary_name": "Piperacillin and Tazobactam and Sodium Chloride",
  "start_marketing_date": "20250930",
  "active_numerator_strength": "4; 500"
}